CareerCross uses cookies to enhance your experience on our websites. If you continue to view our sites without changing your browser settings, then it is assumed that we have your consent to collect and utilise your cookies. If you do not want to give us your consent, then please change the cookie settings on your browser. Please refer to our privacy policy for more information.
CareerCross uses cookies to enhance your experience on our websites. If you continue to view our sites without changing your browser settings, then it is assumed that we have your consent to collect and utilise your cookies. If you do not want to give us your consent, then please change the cookie settings on your browser. Please refer to our privacy policy for more information.
tigerise Inc.
Company Description
Tigerise Ltd. Tigerise Ltd. was established on January 6, 2020 as a joint venture with Hangzhou Taisho Pharmaceutical Technology Co., Ltd. (Hangzhou Tigermed Consulting Co., LTD.; Tigermed), one of the largest Chinese CROs.Support will be provided to overseas pharmaceutical and medical device companies planning global studies in Japan.
Our strengths are services that make the most of Tigermed's specialties and organizations, which have great experiences of clinical development in the Asian region.
Tigerise will provide flexible and innovative proposals and support through collaboration with Japanese experience in clinical development with highly skilled personnel at Accerise Inc.
Tigerise will be Your Footprint to Japan with Powerful Measurement and Specialist!
Company Details
- Head Office
- Japan
- Main Business
- 医薬品・医療機器臨床開発およびサポート業務
- President
- 金 成哲
- Established
- 2020年1月
- Capital
- 8,800万円
- URL
- https://tigerise.co.jp/
Offices
- Main Office
-
Kanda Miyuki Bldg. 8F
1-5-1 Ogawacho, Kanda, Chiyoda-ku
Tokyo, Japan, 1010052
